Logo
Login
$SGMT
$10.42 +$0.86 (9.0%) Close

Company Executives

$SGMT Management Team

Mr. David Happel

President

Chief Executive Officer

Director

Age 63
Compensation $906.2K USD
Sex Male

Ms. Elizabeth Rozek

Chief Compliance Officer

General Counsel

Age 53
Compensation -
Sex Female

Dr. Eduardo Martins

Chief Medical Officer

Age 62
Compensation $669.1K USD
Sex Male

Dr. George Kemble

Executive Chairman of the Board

Age 64
Compensation $930.2K USD
Sex Male

Mr. Thierry Chauche

Chief Financial Officer

Age 49
Compensation $2.407M USD
Sex Male

Board of Directors

From the proxy statement filed Apr 21, 2026
Directors
8
serving now
Independent
0 of 2
stated in the proxy; 6 not stated
Average tenure
5.9 years
from year joined
CEO also chairs the board
No
George Kemble, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Jennifer Jarrett
55 2024
2 years
 Not stated
Audit
Syndax Pharmaceuticals, Inc., Zura Bio Ltd. $157,303
Anne Phillips, M.D.
72 2024
2 years
 Not stated
Nominating and Corporate Governance Compensation
Barinthus Biotherapeutics plc, vTv Therapeutics Inc. $157,109
David Happel
CEO
 64 2022
4 years
 Not independent None stated None stated Paid as CEO
George Kemble, Ph.D.
Board chair
 65 2015
11 years
 Not independent None stated None stated $175,590
Timothy P. Walbert
59 2024
2 years
 Not stated
Audit Compensation
Century Therapeutics, Inc., Mirum Pharmaceuticals, Inc., BioMarin Pharmaceuticals $182,364
Paul Hoelscher
61 2024
2 years
 Not stated
Audit · Chair
None stated $184,864
Elizabeth Grammer, Esq.
62 2021
5 years
 Not stated
Nominating and Corporate Governance · Chair
None stated Not stated
Beth Seidenberg, M.D.
Lead independent director
 69 2007
19 years
 Not stated
Compensation · Chair
Vera Therapeutics, Inc., Kyverna Therapeutics, Inc. $316,278

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 21, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans